Exane Derivatives’s Syngenta Ag SYT Stock Holding History

Exane Derivatives’s Portfolio SYT Stock Details SYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1	Closed	-$64	–	580
2015 Q3	$64	Hold	1	–	–	﹤0.01%	500
2015 Q2	$82	Buy	+1	New	+$80	﹤0.01%	497

Other funds holding SYT

Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Passport Capital San Francisco, California $394M AUM 50.67% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Exane Derivatives's SYT Position: Q4 2015 in Review

Exane Derivatives sold out of Syngenta Ag (SYT) in Q4 2015, closing a stake of 1 share — an estimated $64 sold.

Exane Derivatives first reported a position in SYT in Q2 2015 and held it in 2 quarters. The position peaked at $82 in Q2 2015. 266 funds tracked by Wall St. Rank hold SYT as of Q4 2015.

Exane Derivatives reported no remaining Syngenta Ag position as of Q4 2015 after selling out during the quarter.
Exane Derivatives sold 1 Syngenta Ag share in Q4 2015, an estimated $64.
Exane Derivatives first reported a position in Syngenta Ag in Q2 2015 and held it in 2 quarters.
Exane Derivatives's Syngenta Ag position peaked at $82 in Q2 2015.
266 funds tracked by Wall St. Rank held Syngenta Ag as of Q4 2015.

Based on Exane Derivatives's 13F filing for Q4 2015, filed 11 Feb 2016.